Boundless Bio Inc./$BOLD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Boundless Bio Inc.
Boundless Bio Inc is a clinical-stage oncology company. It is focused on developing cancer therapeutics that address the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Using its proprietary Spyglass platform, the company identifies targets essential for ecDNA functionality, then designs and develops small-molecule drugs called ecDNA-directed therapies (ecDTx) to inhibit those targets. Its main ecDTx candidate under development, BBI-940, is a novel, oral, selective degrader that has demonstrated potent anti-tumor activity across a range of cancer cell lines and mouse xenograft models, including single-agent tumor regressions.
Ticker
$BOLD
Sector
Primary listing
Employees
28
Headquarters
Website
BOLD Metrics
BasicAdvanced
$31m
-
-$2.50
0.97
-
Price and volume
Market cap
$31m
Beta
0.97
52-week high
$1.68
52-week low
$0.96
Average daily volume
112k
Financial strength
Current ratio
9.873
Quick ratio
9.689
Long term debt to equity
52.098
Total debt to equity
55.9
Profitability
EBITDA (TTM)
-59.468
Management effectiveness
Return on assets (TTM)
-22.83%
Return on equity (TTM)
-50.22%
Valuation
Price to book
0.36
Price to tangible book (TTM)
0.36
Price to free cash flow (TTM)
-0.658
Free cash flow yield (TTM)
-151.87%
Free cash flow per share (TTM)
-2.126
Growth
Earnings per share change (TTM)
-15.30%
3-year earnings per share growth (CAGR)
-60.87%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs